News Sentiment

EOLS sentiment intelligence

Evolus Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 56 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 6.61 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

77/100 classification confidence.

Company focus 56

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-4.2% over one week, -1.8% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Analysts Conflicted on These Healthcare Names: Irhythm Technologies (IRTC), Penumbra (PEN) and Evolus (EOLS)

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 77/100 classification
One-week reaction -4.2% Price reacting lower
Trend fit Trend active -1.8% over four weeks
Fair value -33.8% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 17
Neutral 32
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 56
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 6
TradingKey 6
Market source 6
Stock Titan 4
Business Wire 4
Investing.com 3
simplywall.st 3
Yahoo! Finance Canada 2

Event Lens

What the news is about

Classified themes
Market update 27
Earnings 16
Deals and strategy 5
Analyst action 4
Guidance 3
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-56 of 56
Stock Titan Direct company coverage

Evolus (EOLS) shareholders approve directors, auditor and say-on-pay at 2026 meeting

At its Annual Meeting of Stockholders held on June 11, 2026, Evolus, Inc. (EOLS) shareholders elected Brady Stewart and Vikram Malik as Class II directors, with terms extending until the 2029 annual meeting. They also ratified Ernst & Young LLP as the independent registered publi

Tone
Neutral 50/100
Event
Market update
Published
12 Jun 2026 20:38
Source
Stock Titan
The Motley Fool Direct company coverage

Why Evolus Stock Soared Today

Tone
Neutral 50/100
Event
Market update
Published
04 Mar 2026 08:00
Source
The Motley Fool